Current status of antihypertensive therapy for elderly patients in Japan

Hypertension Research - Clinical and Experimental

Volumn 19, Issue 4, 1996, Pages 281-290

  Muratani, Hiromi ^a   Fukiyama, Koshiro ^a,b   Kamiyama, Tomomasa ^a   Kimura, Yorio ^a   Abe, Keishi ^b   Ishii, Masao ^b   Fujii, Jun ^b   Kuwajima, Iwao ^b   Shiomi, Toshiaki ^b   Kawano, Yuhei ^b   Mikami, Hiroshi ^b   Ibayashi, Setsuro ^b   Omae, Teruo ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Res Grp Eval of the Effects of Drug Treatm on Hypertension/Other Dis Conditions in the Elderly   (Japan)

Author keywords

Antihypertensive therapy; Calcium channel blocker; Elderly patient; Risk factor; Target organ damage

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0030477190     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.19.281     Document Type: Article

References (36)

1. Amery A, Birkenhäger W, Brixko P, et al: Mortality and morbidity results from the European Working Party on Hieh Blood Pressure in the Elderly Trial. Lancet 1985; 1: 1349-1354.
2. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 266: 3255-3264.
3. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
4. Medical Research Council Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-412.
5. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The Fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
6. WHO Expert Committee on Diabetes Mellitus: Second Report; Technical Report Series 646, WHO, Geneva, 1985.
7. SAS Institute: SAS/STAT Guide for Personal Computers. 6th ed. Gary, North Carolina, SAS Institute, 1985.
8. Ogihara T, Morimoto S, Nakahashi T, et al: Therapeutic policy for elderly hypertensives in Japan - a questionnaire survey of specialists (in Japanese with English abstract). Jpn J Geriat 1994; 31: 396-403.
9. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH: Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995; 345: 825-829.
10. Bulpitt CJ, Fletcher AE, Amery A, et al: The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials. Drugs Aging 1994; 5: 171-183.
11. Ogilvie RI, Burgess E, Cusson J, Feldman RD, Leiter LA, Myers MG: Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologie treatment of essential hypertension. Can Med Assoc J 1993; 149: 575-584.
12. Sever P, Beevers G, Bulpitt C, et al: Management guidelines in essential hypertension: report of the Second Working Party of the British Hypertension Society. Br Med J 1993; 306: 983-987.
13. Jackson R, Barham P, Bills J, et al: The management of raised blood pressure in New Zealand. Br Med J 1993; 307: 107-110.
14. Tobian L, Brunner HR, Cohn JN, et al: Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens 1994; 7: 859-872.
15. Gribbin B, Pickering TG, Sleight P, Peto R: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971; 29: 424-429, 1971.
16. Shimada K, Kitazumi T, Sadakane N, Ogura H, Ozawa T: Age related changes of baroreflex function, plasma norepinephrine, and blood pressure. Hypertension 1985; 7: 113-117.
17. Glynn RJ, Brock DB, Harris T, et al: Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995; 155: 1855-1860.
18. Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J: Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension 1995; 25: 1045-1051.
19. Ford GA, Asghar MN: Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians. Br J Clin Pharmac 1995; 39: 465-469.
20. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA 1995; 274: 620-625.
21. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
22. Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ: Long-term survival and use of anti-hypertensive medications in older persons. J Am Geriatr Soc 1995; 43: 1191-1197.
23. Opie LH, Messerli FH: Nifedipine and mortality: grave defects in the dossier. Circulation 1995; 92: 1068-1073.
24. Buring JE, Glynn RJ, Hennekens CH: Calcium channel blockers and myocardial infarction: a hypothesis formulated but not yet tested. JAMA 1995; 274: 654-655.
25. Neaton JD, Grimm RH, Jr, Prineas RJ, et al: Treatment of mild hypertension study: final results. JAMA 1993; 322: 569-574.
26. Waldemar G, Schmidt JF, Andersen AR, Vorstrup S, Ibsen H, Paulsen OB: Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man. J Hypertens 1989; 7: 229-235.
27. Torup M, Waldemar G, Paulson OB: Ceranapril and cerebral blood flow autoregulation. J Hypertens 1993; 11: 399-405.
28. Yusuf S, Pepine CJ, Garces C, et al: Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173-1178.
29. Pfeffer MA, Braunwald E, Moye LA, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunciton after myocardial infarction. Results of the survival and ventricular enlargement trail. New Engl J Med 1992; 327: 669-677.
30. Fodor JG, Chockalingam A, Drover A, Fifield F, Pauls CJ: A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension. J Clin Pharmacol 1987; 27: 892-901.
31. Yasue H, Takizawa A, Nagao M, et al: Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
32. Shimokawa H, Nagasawa K, Irie T, et al: Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol 1988; 18: 331-349.
33. Pasternak RC, Braunwald E, Sobel BE: Acute myocardial infarction, in Braunwald E (ed): Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia, Saunders, 1992, pp 1200-1291.
34. Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G: Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988; 259: 1976-1982.
35. D'agostino RB, Belanger AJ, Kannel WB, Cruickshank JM: Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study. Br Med J 1991; 303: 385-389.
36. Irie K, Yamaguchi T, Minematsu K, Omae T: The Jcurve phenomenon in stroke recurrence. Stroke 1993; 24: 1844-1849.